Background: The prevalence of Cutaneous Leishmaniasis (CL) has been reported as 1.8 to 37.9 in different provinces of Iran. However, enough knowledge about epidemiological aspects of CL disease is needed to launch a proper program to plan control and preventive strategies about the disease. Objectives: The present study aimed to determine the epidemiological aspect of CL in Iran during the first 6 months of 2014. Patients and Methods: In this cross-sectional study, all cases of CL reported to centers for disease control and prevention (CDC) by state health departments from March 2014 to September 2014 were included. Descriptive statistics including frequency tables, measures of central value, and measures of dispersion to describe the study...
Background: Leishmaniasis occurs with an incidence of 0.5�1.5 million new cases annually, and is a...
AbstractIntroductionLeishmaniasis, as a major health concern exists in 14 out of 22 countries of the...
Background & Aims of the Study: Cutaneous leishmaniasis (CL) is one of the re-emerging diseases in m...
AbstractObjectiveTo examine the prevalence and clinical manifestations of cutaneous leishmaniasis (C...
Introduction: Leishmaniasis, as a major health concern exists in 14 out of 22 countries of the Easte...
Objective: To examine the prevalence and clinical manifestations of cutaneous leishmaniasis (CL) in ...
&n...
Background: The objective of this study was to assess the magnitude of the cutaneous leishmaniasis (...
Background: Cutaneous leishmaniasis is one of the most important infectious diseases in eastern Medi...
Aim: The prevalence of cutaneous leishmaniasis (CL) is growing in Iran, and new sources of the disea...
Background: Major endemic foci of cutaneous leishmaniasis are present in different areas of Iran, in...
BACKGROUND: Cutaneous Leishmaniasis (CL) isn’t a deadly disease, but it has always been taken into...
SummaryObjectivesThis study was performed to evaluate the epidemiological status of cutaneous leishm...
SummaryObjectivesThis study was performed to evaluate the epidemiological status of cutaneous leishm...
<p style="text-align: justify;"><strong><br />Background: </strong>Cutaneous leishmaniasis (CL) is a...
Background: Leishmaniasis occurs with an incidence of 0.5�1.5 million new cases annually, and is a...
AbstractIntroductionLeishmaniasis, as a major health concern exists in 14 out of 22 countries of the...
Background & Aims of the Study: Cutaneous leishmaniasis (CL) is one of the re-emerging diseases in m...
AbstractObjectiveTo examine the prevalence and clinical manifestations of cutaneous leishmaniasis (C...
Introduction: Leishmaniasis, as a major health concern exists in 14 out of 22 countries of the Easte...
Objective: To examine the prevalence and clinical manifestations of cutaneous leishmaniasis (CL) in ...
&n...
Background: The objective of this study was to assess the magnitude of the cutaneous leishmaniasis (...
Background: Cutaneous leishmaniasis is one of the most important infectious diseases in eastern Medi...
Aim: The prevalence of cutaneous leishmaniasis (CL) is growing in Iran, and new sources of the disea...
Background: Major endemic foci of cutaneous leishmaniasis are present in different areas of Iran, in...
BACKGROUND: Cutaneous Leishmaniasis (CL) isn’t a deadly disease, but it has always been taken into...
SummaryObjectivesThis study was performed to evaluate the epidemiological status of cutaneous leishm...
SummaryObjectivesThis study was performed to evaluate the epidemiological status of cutaneous leishm...
<p style="text-align: justify;"><strong><br />Background: </strong>Cutaneous leishmaniasis (CL) is a...
Background: Leishmaniasis occurs with an incidence of 0.5�1.5 million new cases annually, and is a...
AbstractIntroductionLeishmaniasis, as a major health concern exists in 14 out of 22 countries of the...
Background & Aims of the Study: Cutaneous leishmaniasis (CL) is one of the re-emerging diseases in m...